echinocandin-b and Virus-Diseases

Fungal infection remains a major hurdle in solid organ transplantation. A variety of new antifungal agents have become available and new diagnostic tools are in development. This conference was convened to review current approaches to the prevention and treatment of fungal infection in transplantation. Among the keys to successful management of fungal infection are identification of patients at risk for infection (stratification), eradication or control of established infection in advance of transplantation, the demonstration of cure by radiologic and histopathologic means, and the use of surgical debridement, reduction in immune suppression, and fungicidal therapies whenever possible. The absence of sensitive diagnostic tools and standardization of antifungal susceptibility testing for the filamentous fungi are identified as major impediments to care in this area.

Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Causality; Echinocandins; Fungal Proteins; Fungi; Humans; Mycoses; Organ Transplantation; Peptides; Peptides, Cyclic; Postoperative Complications; Risk Factors; Time Factors; Transplantation; Virus Diseases